- Home
- RRGB vs TENX Comparison
RRGB vs TENX Comparison
Compare RRGB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRGB | TENX |
|---|---|---|
| Founded | 1969 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 56.2M |
| IPO Year | 2002 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RRGB | TENX |
|---|---|---|
| Price | $3.50 | $14.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $9.50 | ★ $29.67 |
| AVG Volume (30 Days) | 319.6K | ★ 422.9K |
| Earning Date | 05-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.43 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,315,014,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $4.64 |
| 52 Week High | $7.52 | $18.38 |
Technical Indicators
Market Signals| Indicator | RRGB | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 53.22 |
| Support Level | $3.20 | $12.71 |
| Resistance Level | $4.42 | $16.61 |
| Average True Range (ATR) | 0.23 | 1.12 |
| MACD | 0.08 | -0.10 |
| Stochastic Oscillator | 86.81 | 40.27 |
Price Performance
Historical ComparisonAbout RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.